United States · FDA National Drug Code directory
BEQALZI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72579-022_6c13a497-8849-4b37-a84d-692910963567
- Product NDC
- 72579-022
- Form
- TABLET, FILM COATED
- Composition / generic term
- sonrotoclax
- Labeler
- BeOne Medicines USA, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20260831
- Source listing expiry
- 20271231
Source-listed ingredients
- SONROTOCLAX — 80 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (72579-022-01) / 11 TABLET, FILM COATED in 1 BLISTER PACK · 72579-022-01
- 1 BOTTLE in 1 CARTON (72579-022-08) / 120 TABLET, FILM COATED in 1 BOTTLE · 72579-022-08
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →